Literature DB >> 28603026

Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence.

Cristina Cadoni1, Augusta Pisanu2, Nicola Simola3, Lucia Frau3, Pier Francesca Porceddu3, Silvia Corongiu3, Christian Dessì2, Annesha Sil3, Antonio Plumitallo4, Jadwiga Wardas5, Gaetano Di Chiara6.   

Abstract

Although MDMA (3,4-methylendioxymethamphetamine, ecstasy) neurotoxicity in serotonin neurons is largely recognized in a wide variety of species including man, neurotoxicity in dopamine (DA) neurons is thought to be species-specific. MDMA is mainly consumed by adolescents, often in conjunction with caffeine (Energy Drinks) and this association has been reported to exacerbate MDMA toxic effects. In order to model these aspects of MDMA use, vis-à-vis their impact on DA neurons, we investigated the effects of adolescent exposure to low doses of MDMA (5 mg/kg for 10 days), alone or in combination with caffeine (10 mg/kg) on neuronal and functional DA indices and on recognition memory in adult rats. MDMA reduced density of tyrosine hydroxylase (TH) positive neurons in the ventral tegmental area and in the substantia nigra pars compacta, and immunoreactivity of TH and DA transporter in the nucleus accumbens (NAc) shell and core, and caudate-putamen. This same treatment caused a reduction of basal dialysate DA in the NAc core. MDMA-pretreated rats also showed behavioral sensitization to a MDMA challenge at adulthood and potentiation of MDMA-induced increase of dialysate DA in the NAc core, but not in the NAc shell. In addition, MDMA-treated rats displayed a deficit in recognition memory. Caffeine co-administration did not affect the above outcomes. Our results show that adolescent exposure of rats to low doses of MDMA induces long-lasting and widespread reduction of DA neurons indicative of a neurotoxic effect on DA neurons and suggestive of a degeneration of the same neurons.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3,4-methylendioxymethamphetamine (PubChem CID: 1615); Caffeine; Caffeine (PubChem CID: 2519); MDMA; Neurotoxicity; Nucleus accumbens; Recognition memory; Sensitization; tyrosine hydroxylase

Mesh:

Substances:

Year:  2017        PMID: 28603026     DOI: 10.1016/j.neuropharm.2017.06.008

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity.

Authors:  Giulia Costa; Micaela Morelli; Nicola Simola
Journal:  Neurotox Res       Date:  2018-04-09       Impact factor: 3.911

2.  Effects of amphetamine exposure during adolescence on behavior and prelimbic cortex neuron activity in adulthood.

Authors:  Luke K Sherrill; Joshua M Gulley
Journal:  Brain Res       Date:  2018-05-21       Impact factor: 3.252

3.  The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice.

Authors:  Neha Milind Chitre; Monique Simone Bagwell; Kevin Sean Murnane
Journal:  Behav Brain Res       Date:  2019-12-03       Impact factor: 3.332

4.  Effects of adolescent caffeine consumption on cocaine self-administration and reinstatement of cocaine seeking.

Authors:  Tracey A Larson; Casey E O'Neill; Michaela P Palumbo; Ryan K Bachtell
Journal:  J Psychopharmacol       Date:  2018-11-28       Impact factor: 4.153

Review 5.  Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.

Authors:  Giulia Costa; Maria Antonietta De Luca; Gessica Piras; Jacopo Marongiu; Liana Fattore; Nicola Simola
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.